This inventor holds 5 USPTO granted patents and 6 published patent applications and 4 EPO patents. Top assignees: National Cerebral and Cardiovascular Center, Shionogi Company Limited, Kabushiki Kaisha Yakult Honsha. Active years: 2016-2025.
Location History:
- Osaka, JP (2016 - 2018)
- Suita, JP (2018)
Company Filing History:
5 out of 51 
3 out of 1,001 
1 out of 215 
Years Active: 2016-2025
Title: The Innovative Contributions of Takashi Nojiri
Introduction
Takashi Nojiri is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medical science, particularly in cancer treatment. With a total of five patents to his name, Nojiri's work focuses on enhancing immune responses and developing novel medicaments for tumor suppression.
Latest Patents
Nojiri's latest patents include an "Antitumor Effect Potentiator," which serves as an activator suitable for immune response in tumor immunotherapy using an immune checkpoint inhibitor. This agent is designed to enhance the antitumor effect of immune checkpoint inhibitors and may contain probiotics and prebiotics as active ingredients. Another notable patent is for a "Medicament for Suppressing Malignant Tumor Metastasis." This innovative medicament aims to suppress or prevent the metastasis of malignant tumors, such as carcinoma, using a non-peptidic angiotensin type 2 receptor agonist as an active ingredient. The medicament can also be used in combination with anticancer and antitumor agents.
Career Highlights
Throughout his career, Takashi Nojiri has worked with esteemed organizations, including the National Cerebral and Cardiovascular Center and Shionogi & Company Limited. His experience in these institutions has allowed him to develop groundbreaking treatments that address critical health challenges.
Collaborations
Nojiri has collaborated with notable colleagues, including Kenji Kangawa and Hiroshi Hosoda. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Takashi Nojiri's innovative work in cancer treatment exemplifies the impact of dedicated research and collaboration in the medical field. His patents reflect a commitment to improving patient outcomes and advancing therapeutic options for malignant tumors.